ISPOR - HPR249 Utilization and Expenditure on Sacubitril/Valsartan (Entresto®) Over a Five-Year Period Under a Reimbursement Application System in Ireland

Full Text

HPR249 Utilization and Expenditure on Sacubitril/Valsartan (Entresto®) Over a Five-Year Period Under a Reimbursement Application System in Ireland

Abstract

Authors

S Doran A Smith M Barry C Gorry

Back to Volume 27, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now